Login & Signup

  • PreIPO
  • Startup Fund Raising
  • Valuations
  • Equity Restructing

  • Investments
  • Mutual Funds
  • Demat Account
  • Bonds/NCD
  • Insurance
  • Life Insurance
  • Health Insurance
  • Car Insurance
  • Corporates & Business
  • Property Insurance
  • Group Health Insurance
  • Marine Insurance

06 July, 2021

Martin and Harris Laboratories Pre IPO (Review & Analysis) 2021| Martin & Harris Unlisted Shares

Discover and get info Martin and Harris Laboratories Pre IPO Share, Unlisted, and Delisted Share Stock before buying, selling, or investing. In this video you will get to know about Martin and Harris Laboratories Complete Review, Analysis, Products, Strengths, Financials & Valuations, Promoters, latest News, and estimated returns.

Martin and Harris Laboratories Ltd incorporated in 1996 at Gurgaon, Haryana is a part of “Apeejay Group”, India’s oldest and largest business conglomerates.

Martin and Harris Laboratories Ltd is engaged in the manufacturing of Pharmaceutical, medicinal chemical & botanical products. Besides the core business, it undertakes the management of its funds through investment in different avenues fetching good returns i.e mutual funds, equity –quoted & unquoted, etc.

The company has its units located at Roorkee and UNA Himachal Pradesh. It is constantly taking steps to modernize and expand its manufacturing units to meet international standards.

The Company has been awarded “Best Innovative in process & formulation development” by director general of health service, ministry of the health & family welfare, Government of India. Has also received “Pharma Excellence Awards 2018” by apex industry chamber ASSOCHAM.

Martin and Harris Laboratories Limited is a manufacturing arm of Walter Bushnell –One of India’s most well renowned Pharma Company. Walter Bushnell is also a part of the Apeejay Stya & Svran Group of companies.

Our Services:
-Pre IPO’s
-ESOP
-Investment Banking
-Pitch deck & Fund Raising for Start-ups
-Life, Health, Car & General Insurance